diabetes
LumiraDx Obtains CE Mark for Point-of-Care HbA1c Test
The assay is used to monitor individuals with diabetes and aid in the screening and identification of patients who may be at risk for developing the condition.
FDA Issues Clearances in April to Zeus Scientific, BioMérieux, Roche, Abbott, Others
Zeus Scientific obtained clearance for a test to detect IgG anti-nuclear antibodies and diagnose systemic rheumatic diseases such as systemic lupus erythematosus.
The researchers used mass spec and data analytics to develop lipid profiles that predicted diabetes and cardiovascular disease risk in the distant future.
9am.health to Offer BioReference Laboratories At-Home Blood Draw Service
9am.health said it would offer customers of its type 2 diabetes management services access to BioReference Laboratories' Scarlet Health service.
Alere and Former Diabetic Testing Subsidiary Settle False Claims Allegations for $160M
Now-defunct Arriva Medical and its parent company Alere were accused of paying kickbacks to Medicare beneficiaries.
Jun 30, 2021
Sebia Acquires Dx Firm Orgentec Diagnostika
Nov 17, 2020
Trinity Biotech Q3 Revenues Rise 30 Percent
Apr 22, 2020
Roche Diagnostics Q1 Sales Essentially Flat
Dec 10, 2019
Roche Blood Glucose Monitor App Receives CE Mark
Oct 10, 2019